AzTrials
AzTrials

Emergency MedicineNCT05616416

International Big Data Centre in Emergency Medicine

An observational study of Emergency Medicine, run by Guangdong Provincial People's Hospital at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This observational study aims to use electronic health records to build an International Big Data Centre in Emergency Medicine, within the Institute of Sciences in Emergency Medicine (ISEM) at the Guangdong Provincial People's Hospital. Read more about this study

Who is it for?
Any age
Conditions the study is for
Emergency Medicine
How many people
500,000 participants
Where
1 siteChina
Study dates
1 Jan 2011to Dec 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: The study population will be everybody who visited the Emergency Department.

Who may be able to join

  • Every patient who ever visited Emergency Department from 2011-2022

Who cannot join

  • Patients with missing demographic (age, gender, etc.) and triage data

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Abdelouahab Bellou, MD, PhD, MSc contact

+16176693707

abellou402@gmail.com

China1 site, 1 recruiting
  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong

    Abdelouahab Bellou, MD, +16176693707, abellou402@gmail.com

    Recruiting

Other trials in China

About this study

Official title: Institute of Sciences in Emergency Medicine - International Big Data Centre in Emergency Medicine

This observational study aims to use electronic health records to build an International Big Data Centre in Emergency Medicine, within the Institute of Sciences in Emergency Medicine (ISEM) at the Guangdong Provincial People's Hospital. The main questions it seeks to answer are not limited to the following:

  • Identify the relationship between Emergency Department Length of Stay (EDLOS), Mortality, and Adverse Events (AE)
  • Identify the risk factors associated with high mortality and AE rate among patients who experience prolonged EDLOS
  • Other research questions related to emergency medicine, such as building prediction and cluster models for acute diseases
Read the detailed description

The relationship between the emergency department length-of-stay (EDLOS), mortality, and adverse events (AE) rate remains unclear and underestimated. EDLOS is the time elapsed between the time of arrival and the time of the release of a patient admitted to ED. Mortality is defined as short-term (14 hours, 48 hours, 7 days, 15 days) and 30 days death of patients managed in the ED discharged or admitted. An AE is an event that can result whether from medical mismanagement or happen by accident and causes physical and mental harm to the patient during the stay and remains after leaving. To separate the mismanagement from accidental causes i.e., compliant management but the unfortunate situation or persons, this study will refer to indicators that are objectively measurable and can be compared at different times throughout the patient's stay in the ED.

The hypothesis is that a prolonged stay of the patients in the ED especially without diagnosis or decision of admission is associated with increased mortality and AEs. This project will test this hypothesis through a prospective international multicenter study in contributing to whether a prolonged EDLOS is associated with an increased rate of adverse outcomes.

Keywords
Machine Learning, Data Mining, Artificial Intelligence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05616416
Study groupRoleWhat they receive
All ED PatientAll patients visited the emergency department during the period.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. In-hospital Mortality

    IHM

    Measured: From date of ED triage until the date of discharge or date of death from any cause, whichever came first, assessed up to 1 month

Secondary outcomes (1)
  1. Number of Adverse Events

    AE

    Measured: From date of ED triage until the date of discharge or date of death from any cause, whichever came first, assessed up to 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2022
  2. Study start1 Jan 2011
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05616416
Sponsor's protocol ID
KY-N-2022-105-01
Status last verified
Jun 2026
First submitted
7 Nov 2022
Last updated
1 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Medicine, run by Guangdong Provincial People's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 1 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Abdelouahab Bellou, MD, PhD, MSc (+16176693707, abellou402@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

In-hospital Mortality (time frame: From date of ED triage until the date of discharge or date of death from any cause, whichever came first, assessed up to 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in